[{"AccountsPayableCurrent_0_Q2_USD":10238000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":19949000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":7114000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2352000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":100000.0,"ShortTermInvestments_0_Q2_USD":611265000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":166139000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":611053000.0,"AvailableForSaleSecurities_0_Q2_USD":611265000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":16.2,"PaymentsToAcquireAvailableForSaleSecurities_2_Q2_USD":534717000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":97000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":10537000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-595000.0,"InvestmentIncomeInterest_2_Q2_USD":1824000.0,"InvestmentIncomeInterest_1_Q2_USD":609000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":512000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-132516000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-63613000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":151131000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2085000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":18813000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":567000000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":567000000.0,"SecurityDeposit_0_Q2_USD":5500000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":5188000.0,"OtherAssetsNoncurrent_0_Q2_USD":3182000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q2_USD":-165000.0,"AssetsFairValueDisclosure_0_Q2_USD":611265000.0,"ShortTermLeaseCost_2_Q2_USD":31000.0,"ShortTermLeaseCost_1_Q2_USD":14000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":19949000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":10537000.0,"RestrictedCash_0_Q2_USD":5525000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":216678000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":283000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.075,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":3195000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":7480000.0,"OperatingLeasePayments_2_Q2_USD":4102000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_2_Q2_USD":-283000.0,"OperatingLeasePayments_1_Q2_USD":1906000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5873000.0,"OperatingLeaseLiability_0_Q2_USD":7874000.0,"OperatingLeaseCost_2_Q2_USD":3709000.0,"OperatingLeaseCost_1_Q2_USD":2073000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":1000000.0,"LeaseCost_2_Q2_USD":6371000.0,"LeaseCost_1_Q2_USD":3347000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":146720000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":777400000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":9000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":326000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2001000.0,"VariableLeaseCost_1_Q2_USD":1260000.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q2_USD":115000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":338000.0,"NetIncomeLoss_1_Q2_USD":-63018000.0,"NetIncomeLoss_2_Q2_USD":-132613000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-101927000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-323651000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":572298000.0,"LiabilitiesNoncurrent_0_Q2_USD":4353000.0,"LiabilitiesCurrent_0_Q2_USD":54905000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":817567000.0,"Liabilities_0_Q2_USD":59258000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1064000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-7096000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5612000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":28211000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.02,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.47,"CommonStockValue_0_Q2_USD":6000.0,"CommonStockSharesOutstanding_0_Q2_shares":146434810.0,"CommonStockSharesIssued_0_Q2_shares":146434810.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":160614000.0,"AssetsCurrent_0_Q2_USD":782654000.0,"Assets_0_Q2_USD":817567000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16272855.0,"AdditionalPaidInCapital_0_Q2_USD":1461207000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":317000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14353000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":4140000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10775000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":567393000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":265000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q2_USD":273000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":8326000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":5212000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":-17000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1237000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":5188000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":19949000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":106226000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":49274000.0,"ProceedsFromIssuanceOfCommonStock_0_Q2_USD":567000000.0,"OperatingIncomeLoss_2_Q2_USD":-134437000.0,"OperatingExpenses_2_Q2_USD":134437000.0,"OperatingExpenses_1_Q2_USD":63627000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":38794000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":129848.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":133162.0,"StockholdersEquity_0_Q2_USD":758309000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-703225000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":18726000.0,"OperatingIncomeLoss_1_Q2_USD":-63627000.0,"VariableLeaseCost_2_Q2_USD":2631000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]